Nutritional markers and prognosis in cardiac cachexia

International Journal of Cardiology

Volumn 146, Issue 3, 2011, Pages 359-363

  Araújo, José Paulo ^a   Lourenço, Patrícia ^a   Rocha Gonçalves, Francisco ^a   Ferreira, António ^a   Bettencourt, Paulo ^a  

^a Heart Failure Clinic   (Portugal)

Author keywords

Cardiac cachexia; Catabolism; Heart failure; Inflammation; Nutrition

Indexed keywords

ALBUMIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; HEMOGLOBIN; PREALBUMIN; TRANSFERRIN; TRIACYLGLYCEROL;

AGED; ALBUMIN BLOOD LEVEL; AMBULATORY CARE; ANTHROPOMETRY; ARTICLE; CACHEXIA; CHOLESTEROL BLOOD LEVEL; FEMALE; FOLLOW UP; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROGNOSIS; TRANSFERRIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

AGED; CACHEXIA; CHRONIC DISEASE; FEMALE; HEART FAILURE; HUMANS; MALE; NUTRITIONAL STATUS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 78951485094     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.07.042     Document Type: Article

References (25)

1. Hoes, and Mosterd Clinical epidemiology of heart failure Heart 93 2007 1137 1146
2. S.D. Anker, P. Ponikowski, and S. Varney Wasting as independent risk factor for mortality in chronic heart failure Lancet 349 1997 1050 1053
3. S.D. Anker, A. Negassa, and A. Coats Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin- converting inhibitors: an observational study Lancet 361 2003 1077 1083
4. A. Katz, and P. Katz Diseases of heart in works of Hippocrates Br Heart J 24 1962 257 264
5. B. Levine, J. Kalman, L. Mayer, H.M. Filit, and M. Packer Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 323 1990 236 241
6. S.D. Anker, T.P. Chua, and P. Ponikowski Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia Circulation 96 1997 526 534
7. D.R. Murdoch, E. Rooney, H.J. Darge, D. Shapiro, J.J. Morton, and J.J. McMurray Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure Heart 82 1999 352 356
8. M.B. McEntergart, B. Awede, and M.C. Petrie Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide Eur Heart J 28 2007 829 835
9. N. Nagaya, M. Uematsu, and M. Kojima Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors Circulation 104 2001 2034 2038
10. R. Aquilani, C. Opasich, and M. Verri Is nutritional intake adequate in chronic heart failure patients? J Am Coll Cardiol 42 2003 1218 1223
11. D. King, M.L. Smith, T.J. Chapman, H.R. Stockdale, and M. Lye Fat mal-absorption in elderly patients with cardiac cachexia Age Ageing 25 1996 144 149
12. M. Cicoira, P.R. Kalra, and S.D. Anker Growth Hormone resistance in chronic heart failure and its therapeutic implications J Card Fail 9 2003 219 225
13. Y. Moriyama, H. Yasue, and M. Yoshimura The plasma levels of dehydroepiandrosterone sulphate are decreased in patients with chronic heart failure in proportions to the severity J Clin Endocrinol Metab 85 2000 1834 1840
14. J. McMurray, I. Abdullah, H.J. Dargie, and D. Shapiro Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure Br Heart J 66 1991 356 358
15. K. Swedberg, J. Cleland, and H. Dargie Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Eur Heart J 26 2005 1115 1140
16. K.F. Rabe, S. Hurd, and A. Anzueto Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 2007 532 555
17. U.G. Kyle, I. Bosaeus, and A.D. de Lorenzo Bioelectrical impedance analysis: utilization in clinical practice Clin Nutr 23 2004 1430 1453
18. Ingenbleek Y. Ferard Place actuelle de la tranthyretine en biologie clinique Ann Biol Clin 61 2003 358 362
19. D. Hrnciarikova, B. Juraskova, and R. Hysper A changed view of serum pre-albumin in the elderly: pre-albumin values influenced by concomitant inflammation Biomed Pap Med Fac Univ Palcky Olomouc Czech Repub 151 2007 273 276
20. J. Doust, E. Pietrzak, A. Dobson, and P. Glasziou How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: a systematic review BMJ 330 2005 625
21. M. Rauchhaus, A.L. Clark, and W. Doehner The relationship between cholesterol and survival in patients with chronic heart failure J Am Coll Cardiol 42 2003 1933 1940
22. T.B. Horwich, M.A. Hamilton, R. Maclellan, and G.C. Fonarow Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure J Card Fail 8 2002 216 223
23. J.P. Araújo, F. Friões, A. Azevedo, P. Lourenço, F. Rocha-Gonçalves, and A. Ferreira Cholesterol - a marker of nutritional status in mild to moderate heart failure Int J Cardiology 129 2008 65 68
24. M. Rauchhaus, A.J.S. Coats, and S.D. Anker The endotoxin-lipoprotein hypothesis Lancet 356 2000 930 933
25. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150